Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study

Leuk Lymphoma. 2018 Jan;59(1):225-228. doi: 10.1080/10428194.2017.1321748. Epub 2017 Jun 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Biosimilar Pharmaceuticals / pharmacology*
  • Female
  • Filgrastim / pharmacology*
  • Hematologic Agents / pharmacology
  • Hematopoietic Stem Cell Mobilization / methods*
  • Humans
  • Leukemia, Myeloid / pathology
  • Leukemia, Myeloid / therapy*
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation / methods*
  • Peripheral Blood Stem Cells / drug effects*
  • Retrospective Studies
  • Transplantation, Autologous
  • Treatment Outcome
  • Young Adult

Substances

  • Biosimilar Pharmaceuticals
  • Hematologic Agents
  • Filgrastim